Effects of chloride conductance inhibitors on fluid secretion into ligated ileal and jejunal loops in pigs.
Compounds that prevent chloride transport in membrane vesicles have been tested for in vivo activity against the effects of intestinal secretory agents. Chloride channel blockers including diphenylamine-2-carboxylate, 4-acetamido-4'-isothiocyanostilbene-2,2'-disulfonate, 5-nitro-2-(2-phenylethylamino)benzoic acid, and alpha-phenylcinnamic acid were tested for effects on jejunal or ileal secretion in weanling pigs. Secretion was studied in ligated intestinal loops in a control state, during exposure to secretory concentrations of theophylline, and after prior treatment with cholera toxin. Increases in net fluid flux induced by either theophylline or cholera toxin were not prevented by adding chloride channel blockers into the intestinal lumen. Channel blocker concentrations that reduced chloride transport by greater than 50% in pig jejunal brush border vesicles did not cause significant changes in unidirectional blood to lumen chloride flux measured in situ. Several routes of administration of the specific chloride channel blocker alpha-phenylcinnamate failed to reduce fluid secretion induced by theophylline. Chloride channel blocker effectiveness appears to be significantly different between in vitro and in vivo experimental models. In contrast to the chloride channel blockers, loperamide significantly reduced net fluid and chloride flux in ileal loops secreting fluid in response to theophylline. Antagonism of the production or actions of second messenger by loperamide was more effective than the chloride channel blockers in reducing conductive chloride transport associated with intestinal secretion.
Forsyth
G W
GW
Department of Veterinary Physiological Sciences, College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada.
Gabriel
S E
SE
D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid / Q000494:pharmacology*; D000818:Animals; D018118:Chloride Channels; D002772:Cholera Toxin / Q000494:pharmacology; D002934:Cinnamates / Q000494:pharmacology; D007082:Ileum / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D007583:Jejunum / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D008026:Ligation / Q000662:veterinary; D008139:Loperamide / Q000494:pharmacology; D008565:Membrane Proteins / Q000037:antagonists & inhibitors* / Q000187:drug effects; D013552:Swine / Q000502:physiology*; D013806:Theophylline / Q000037:antagonists & inhibitors / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
D018118:Chloride Channels; D002934:Cinnamates; D008565:Membrane Proteins; D062367:ortho-Aminobenzoates; D012856:4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; C061614:alpha-phenylcinnamate; D008139:Loperamide; D002772:Cholera Toxin; C001209:fenamic acid; D013806:Theophylline